Zoetis Inc. Employee Count
The employee counts Zoetis Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 1,700; Filing 2026-02-12; Lease expense per employee $65,294.12.
- 2024-12-31: Employees (as filed) 1,600; Filing 2025-02-13; Lease expense per employee $56,875.00.
- 2023-12-31: Employees (as filed) 1,600; Filing 2024-02-13; Lease expense per employee $55,000.00.
- 2022-12-31: Employees (as filed) 1,430; Filing 2023-02-14; Lease expense per employee $52,447.55.
- Available history
- 2012-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 1,700 | 2026-02-12 | $65,294.12 total lease cost |
| 2024-12-31 | 1,600 | 2025-02-13 | $56,875.00 total lease cost |
| 2023-12-31 | 1,600 | 2024-02-13 | $55,000.00 total lease cost |
| 2022-12-31 | 1,430 | 2023-02-14 | $52,447.55 total lease cost |
| 2021-12-31 | 1,300 | 2022-02-15 | $60,000.00 total lease cost |
| 2020-12-31 | 1,250 | 2021-02-16 | |
| 2019-12-31 | 1,100 | 2020-02-13 | |
| 2018-12-31 | 1,100 | 2019-02-14 | $40,909.09 rent expense, net |
| 2017-12-31 | 1,000 | 2018-02-15 | $27,000.00 rent expense, net |
| 2016-12-31 | 1,000 | 2017-02-16 | $25,000.00 rent expense, net |
| 2015-12-31 | 1,050 | 2016-02-24 | $24,761.90 rent expense, net |
| 2014-12-31 | 1,100 | 2015-02-27 | $26,363.64 rent expense, net |
| 2013-12-31 | 1,100 | 2014-03-26 | $29,090.91 rent expense, net |
| 2012-12-31 | 1,000 | 2013-03-28 | $17,000.00 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |